New Database Portal for Complementary Medicine

The Karl und Veronica Carstens Foundation is launching a free database portal for complementary medicine, naturopathy and homeopathy. In total, 96,000 items of scientific literature, among them more than 30,000 clinical research papers and more than 9,000 basic research publications, can now be searched for free – a service unique in form and scale for scientists, practitioners, therapists and students.    Source: Data portal

TGA Releases Latest Version of Australian Regulatory Guidelines for Complementary Medicines (ARGCM)

The Australian Regulatory Guidelines for Complementary Medicines (ARGCM) provide information for manufacturers, sponsors, healthcare professionals and the general public on the regulation of complementary medicines in Australia. This most recent Version 7.0 was released in October 2017 and has been re-structured to increase accessibility for intended users.    Source: Reg. guidelines 

TGA Presents Revised Draft List of Permitted Indications

The first draft list of permitted indications was published on 5 July 2017. A revised draft list has now been published to provide stakeholders with the opportunity to review and comment prior to the permitted indications reform coming into effect. Additional supporting materials have also been provided to assist stakeholders in understanding how the list will work and how the regulatory requirements for listed medicines will change. Sponsors should not make regulatory decisions based on this preliminary information, as changes may occur before finalisation and implementation of the supporting legislation. The revised draft list of permitted indications will be available on TGA website until 31 October 2017.    Source: Permitted indications draft

TGA Publishes Outcomes of Advertising Complaints

The Therapeutic Goods Administration lists outcomes where the advertiser has taken specific action to address identified breaches of therapeutic goods advertising legislative requirements and is compliant at the date for which the complaint investigation was finalised. The advertiser's actions have been taken following TGA investigations into these complaints. All of these complaints were the subject of a complaint to the Complaints Resolution Panel. They were referred to the TGA for follow-up action because the advertiser did not fully comply with the Panel's request to address breaches of the therapeutic goods advertising legislation.    Source: Advert outcomes

TGA Publishes Guidelines for Medicinal Marijuana

This guidance is for consumers, health professionals, sponsors and manufacturers who are involved in providing appropriate patients with access to medicinal cannabis products as an unapproved drug through the Special Access Scheme (SAS) or Authorised Prescriber Scheme. The term 'medicinal cannabis products' covers a range of cannabis preparations intended for therapeutic use, including pharmaceutical cannabis preparations, such as oils, tinctures and other extracts.    Source: Medicinal pot

Editor’s note: For those interested in looking at TGA academic studies and research references on marijuana’s impact on pain relief and other medical conditions: Marijuana research

TGA Updates SUSMP ‘Poisons Standard’

The Poisons Standard has been presented with a view to promoting uniform scheduling of substances and uniform labelling and packaging requirements throughout Australia. The Poisons Standard is the legal title of the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP). This latest update has particular relevance for those involved in the supply of cosmetics associated with the ingredients methylisothiazolinone, methylchloroisothiazolinone, and geraniol.    Sources: SUSMP update ; & Legislation

TGA Announces Labelling Changes: Information for Sponsors

The TGA has made several amendments to the new labelling Orders TGO 91 & TGO 92. Many of the recent amendments were made as a direct result of feedback from industry stakeholders. The TGA has also introduced labelling requirements for medicines supplied in Australia. These changes were introduced on 31 August 2016 which started the four year transition period.    Source: Label changes

TGA Publishes Presentations Given at Recent TGA Pharmacovigilance Inspection Program Information Sessions

Presentations cover the pharmacovigilance inspection guidelines, preparing for inspections, inspection process, and close out of inspections.    Source: Pharmacovigilance

TGA Safety AdvisoriesSource: 2017 alerts    

Jimpness Beauty Fat Loss capsules: the capsules contain the undeclared substance phenolphthalein.

 

RFA Breaking News

This issue of RFA Newsletter is sponsored by

        IME  a trusted insurance broker for small to medium businesses, with expertise in risk management, professional indemnity, public & product liability, and property cover. See more…

Readmore..

Complementary Medicines ("Dietary supplements"):

  New Database Portal for Complementary Medicine The Karl und Veronica Carstens Foundation is launching a free database portal for complementary medicine, naturopathy and homeopathy. In total, 96,000 items of…

Readmore..

Foods:

  What You Need to Know About Australia’s Health Star Rating on Foods The Federal Government's Health Star Rating claims to "take some of the guess work out of shopping"…

Readmore..

Cosmetics (& Household cleaning products):

  ACCC Concludes Investigation Into ALDI 'Flushable' Wipes The Australian Competition & Consumer Commission has completed its investigation into ALDI’s ‘flushable’ wipes and will take no further action after ALDI…

Readmore..

Marketing News:

  Marketing Claims Under Scrutiny at Upcoming Colmar Brunton Event Market research agency Colmar Brunton has announced a Melbourne seminar on how to make substantive marketing claims. To be held…

Readmore..

RFA Sends Condolences:

Robert Forbes and all of our associates are aware of the great tragedy that has recently unfolded in USA. As regular visitors to Supply Side West at the Mandalay Bay,…

Readmore..

Go to top